Tang-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "KNSA",
  "NUVL",
  "EWTX",
  "CNTA",
  "INSM",
  "RVMD",
  "ENTA",
  "JAZZ",
  "ACAD",
  "ALXO",
  "BABA",
  "TGTX",
  "ALL",
  "PTCT",
  "AXP",
  "ANIP",
  "ABCL",
  "ADMA",
  "AAT",
  "GLPG",
  "GMAB",
  "DVAX",
  "NVAX",
  "MGX",
  "SWTX",
  "TCRX",
  "AVDL",
  "AUPH",
  "RCKT",
  "ARVN",
  "ANAB",
  "ALT",
  "ATXS",
  "SLRN",
  "TBPH",
  "RLAY",
  "MIRM",
  "THRD",
  "NUVB",
  "LENZ",
  "LQDA",
  "ACET",
  "MNMD",
  "STOK",
  "TECX",
  "MLYS",
  "REPL",
  "PHAT",
  "SNDX",
  "NMRA",
  "KROS",
  "LEGN",
  "ALGS",
  "AFMD",
  "ALLK",
  "ATHA",
  "AMLX",
  "JANX",
  "APLT",
  "ATRA",
  "BIOA",
  "BCAB",
  "HD",
  "BLUE",
  "BOLT",
  "AZN",
  "MCD",
  "EPIX",
  "SYRE",
  "APGE",
  "FATE",
  "TARS",
  "IVVD",
  "NBIX",
  "META",
  "KALV",
  "MGNX",
  "NXTC",
  "OABI",
  "NKTX",
  "OTLK",
  "OKUR",
  "QNCX",
  "PYXS",
  "PBYI",
  "SEER",
  "MCRB",
  "LAB",
  "STRO",
  "IONS",
  "IOVA",
  "CYBN",
  "BLCO",
  "ATYR",
  "MSFT",
  "TMUS",
  "GE",
  "HRTX",
  "HRL",
  "IBRX",
  "ZYME",
  "PAYX",
  "PYPL",
  "UNH",
  "NVDA",
  "HPE",
  "INTC",
  "PFE",
  "PG",
  "VZ",
  "REGN",
  "SHW",
  "TXN",
  "UAL",
  "DTIL",
  null,
  "MRNA",
  "LXRX",
  "PLRX",
  "SLNO",
  "PASG",
  "RVPH",
  "ULTA",
  "SNY",
  "GSK",
  "GRAL",
  "ARE",
  "F",
  null,
  "CMPS",
  "ELEV",
  "ERAS",
  "EOLS",
  "FTRE",
  "IMCR",
  "HRMY",
  "DSGN",
  "HLVX",
  "ITOS",
  "KLRS",
  "DERM",
  "KRON",
  "KURA",
  "KOD",
  "IDXX",
  "KZR",
  "AMZN",
  "VNDA",
  "VTYX",
  "VSTM",
  "VTRS",
  "V",
  "VKTX",
  "VIR",
  "VRDN",
  "WMT",
  "WHR",
  "ZNTL",
  "ELAN",
  "OPRX",
  "VERA",
  "BIIB",
  "BHVN",
  null,
  "TDOC",
  "SEE",
  "LNTH",
  "GEV",
  "PCVX",
  "FDX",
  "AVIR",
  "BRK-B",
  "BEAM",
  null,
  "BDTX",
  "BCRX",
  "BNTX",
  "BA",
  "CCCC",
  "CDNA",
  "CAPR",
  "CRGX",
  "SAVA",
  "IPSC",
  "CVX",
  "CLX",
  "KO",
  "CHRS",
  "CMPX",
  "CRBP",
  "CRSP",
  "CGEM",
  "CTMX",
  "CYTK",
  "DNTH",
  "NKE",
  "DIS",
  "XOM",
  "JNJ",
  "NFLX",
  "JPM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 202
Total Value: 1807581363
Accession Number: 0001214659-25-007882
Form Type: 13F-HR
CIK: tang-capital-management
Manager Name: Tang-Capital-Management

Data Enrichment

98% identified

198 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

202 positions • $1.8B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 11

Sort by:

Nuvation Bio Inc.

NUVB|67080N101

Shares:3.9M

Value:$6.9M

% of Portfolio:0.4% ($6.9M/$1.8B)

ESSA Pharma Inc.

EPIX|29668H708

Shares:4.3M

Value:$6.8M

% of Portfolio:0.4% ($6.8M/$1.8B)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:300.0K

Value:$6.6M

% of Portfolio:0.4% ($6.6M/$1.8B)

Viking Therapeutics, Inc.

VKTX|92686J106

Shares:270.0K

Value:$6.5M

% of Portfolio:0.4% ($6.5M/$1.8B)

Design Therapeutics, Inc.

DSGN|25056L103

Shares:1.7M

Value:$6.5M

% of Portfolio:0.4% ($6.5M/$1.8B)

REGENERON PHARMACEUTICALS, INC.

REGN|75886F107

Shares:10.0K

Value:$6.3M

% of Portfolio:0.4% ($6.3M/$1.8B)

Adicet Bio, Inc.

ACET|007002108

Shares:8.2M

Value:$6.2M

% of Portfolio:0.3% ($6.2M/$1.8B)

BioAge Labs, Inc.

BIOA|09077V100

Shares:1.6M

Value:$6.0M

% of Portfolio:0.3% ($6.0M/$1.8B)

BIOCRYST PHARMACEUTICALS INC

BCRX|09058V103

Shares:800.0K

Value:$6.0M

% of Portfolio:0.3% ($6.0M/$1.8B)

IOVANCE BIOTHERAPEUTICS, INC.

IOVA|462260100

Shares:1.8M

Value:$6.0M

% of Portfolio:0.3% ($6.0M/$1.8B)

AbCellera Biologics Inc.

ABCL|00288U106

Shares:2.6M

Value:$5.8M

% of Portfolio:0.3% ($5.8M/$1.8B)

ROCKET PHARMACEUTICALS, INC.

RCKT|77313F106

Shares:850.0K

Value:$5.7M

% of Portfolio:0.3% ($5.7M/$1.8B)

HERON THERAPEUTICS, INC. /DE/

HRTX|427746102

Shares:2.2M

Value:$4.9M

% of Portfolio:0.3% ($4.9M/$1.8B)

Lantheus Holdings, Inc.

LNTH|516544103

Shares:50.0K

Value:$4.9M

% of Portfolio:0.3% ($4.9M/$1.8B)

Dianthus Therapeutics, Inc. /DE/

DNTH|252828108

Shares:264.7K

Value:$4.8M

% of Portfolio:0.3% ($4.8M/$1.8B)

BIOGEN INC.

BIIB|09062X103

Shares:35.0K

Value:$4.8M

% of Portfolio:0.3% ($4.8M/$1.8B)

IONIS PHARMACEUTICALS INC

IONS|462222100

Shares:150.0K

Value:$4.5M

% of Portfolio:0.3% ($4.5M/$1.8B)

CytomX Therapeutics, Inc.

CTMX|23284F105

Shares:6.7M

Value:$4.3M

% of Portfolio:0.2% ($4.3M/$1.8B)

Merus N.V.

MRUS|N5749R100

Shares:100.0K

Value:$4.2M

% of Portfolio:0.2% ($4.2M/$1.8B)

Coherus BioSciences, Inc.

CHRS|19249H103

Shares:5.1M

Value:$4.1M

% of Portfolio:0.2% ($4.1M/$1.8B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Nuvation Bio Inc.(NUVBcusip67080N101)	3.9M	QoQ 0.00% (-0) YoY +9.80% (-348.1K)	All Managers (Combined)	$6.9M	0.4% ($6.9M/$1.8B)	QoQ -33.83% (-$3.5M) YoY -46.90% (-$6.1M)
ESSA Pharma Inc.(EPIXcusip29668H708)	4.3M	QoQ 0.00% (-0) YoY NEW(+4.3M)	All Managers (Combined)	$6.8M	0.4% ($6.8M/$1.8B)	QoQ -11.73% (-$903.0K) YoY NEW(+$6.8M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	300.0K	QoQ 0.00% (-0) YoY NEW(+300.0K)	All Managers (Combined)	$6.6M	0.4% ($6.6M/$1.8B)	QoQ -17.60% (-$1.4M) YoY NEW(+$6.6M)
Viking Therapeutics, Inc.(VKTXcusip92686J106)	270.0K	QoQ -15.62% (-50.0K) YoY +170.00% (-170.0K)	All Managers (Combined)	$6.5M	0.4% ($6.5M/$1.8B)	QoQ -49.36% (-$6.4M) YoY -20.48% (-$1.7M)
Design Therapeutics, Inc.(DSGNcusip25056L103)	1.7M	QoQ +13.50% (-200.0K) YoY +13.50% (+200.0K)	All Managers (Combined)	$6.5M	0.4% ($6.5M/$1.8B)	QoQ -28.99% (-$2.6M) YoY +8.71% (+$520.2K)
REGENERON PHARMACEUTICALS, INC.(REGNcusip75886F107)	10.0K	QoQ +400.00% (+8.0K) YoY NEW(+10.0K)	All Managers (Combined)	$6.3M	0.4% ($6.3M/$1.8B)	QoQ +345.17% (+$4.9M) YoY NEW(+$6.3M)
Adicet Bio, Inc.(ACETcusip007002108)	8.2M	QoQ +0.95% (-77.6K) YoY +28.34% (-1.8M)	All Managers (Combined)	$6.2M	0.3% ($6.2M/$1.8B)	QoQ -20.76% (-$1.6M) YoY -58.76% (-$8.8M)
BioAge Labs, Inc.(BIOAcusip09077V100)	1.6M	QoQ +21.36% (-281.6K) YoY NEW(+1.6M)	All Managers (Combined)	$6.0M	0.3% ($6.0M/$1.8B)	QoQ -21.18% (-$1.6M) YoY NEW(+$6.0M)
BIOCRYST PHARMACEUTICALS INC(BCRXcusip09058V103)	800.0K	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$6.0M	0.3% ($6.0M/$1.8B)	QoQ -0.26% (-$16.0K) YoY +47.63% (+$1.9M)
IOVANCE BIOTHERAPEUTICS, INC.(IOVAcusip462260100)	1.8M	QoQ +260.00% (+1.3M) YoY +260.00% (-1.3M)	All Managers (Combined)	$6.0M	0.3% ($6.0M/$1.8B)	QoQ +62.00% (+$2.3M) YoY -19.10% (-$1.4M)
AbCellera Biologics Inc.(ABCLcusip00288U106)	2.6M	QoQ +0.66% (-17.2K) YoY NEW(+2.6M)	All Managers (Combined)	$5.8M	0.3% ($5.8M/$1.8B)	QoQ -23.38% (-$1.8M) YoY NEW(+$5.8M)
ROCKET PHARMACEUTICALS, INC.(RCKTcusip77313F106)	850.0K	QoQ +13.33% (-100.0K) YoY +28.78% (-190.0K)	All Managers (Combined)	$5.7M	0.3% ($5.7M/$1.8B)	QoQ -39.86% (-$3.8M) YoY -68.11% (-$12.1M)
HERON THERAPEUTICS, INC. /DE/(HRTXcusip427746102)	2.2M	QoQ +4.44% (+95.2K) YoY +20.83% (-385.5K)	All Managers (Combined)	$4.9M	0.3% ($4.9M/$1.8B)	QoQ +50.18% (+$1.6M) YoY -4.02% (-$206.5K)
Lantheus Holdings, Inc.(LNTHcusip516544103)	50.0K	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$4.9M	0.3% ($4.9M/$1.8B)	QoQ +9.09% (+$407.0K) YoY +56.81% (+$1.8M)
Dianthus Therapeutics, Inc. /DE/(DNTHcusip252828108)	264.7K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.8M	0.3% ($4.8M/$1.8B)	QoQ -16.78% (-$968.8K) YoY -39.53% (-$3.1M)
BIOGEN INC.(BIIBcusip09062X103)	35.0K	QoQ 0.00% (-0) YoY NEW(+35.0K)	All Managers (Combined)	$4.8M	0.3% ($4.8M/$1.8B)	QoQ -10.51% (-$562.8K) YoY NEW(+$4.8M)
IONIS PHARMACEUTICALS INC(IONScusip462222100)	150.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.5M	0.3% ($4.5M/$1.8B)	QoQ -13.70% (-$718.5K) YoY -30.40% (-$2.0M)
CytomX Therapeutics, Inc.(CTMXcusip23284F105)	6.7M	QoQ -8.12% (-593.9K) YoY +4.15% (-267.8K)	All Managers (Combined)	$4.3M	0.2% ($4.3M/$1.8B)	QoQ -43.28% (-$3.3M) YoY -69.62% (-$9.8M)
Merus N.V.(MRUScusipN5749R100)	100.0K	QoQ 0.00% (+0) YoY NEW(+100.0K)	All Managers (Combined)	$4.2M	0.2% ($4.2M/$1.8B)	QoQ +0.09% (+$4.0K) YoY NEW(+$4.2M)
Coherus BioSciences, Inc.(CHRScusip19249H103)	5.1M	QoQ +39.65% (-1.4M) YoY NEW(+5.1M)	All Managers (Combined)	$4.1M	0.2% ($4.1M/$1.8B)	QoQ -18.33% (-$923.4K) YoY NEW(+$4.1M)